Identification of FDA-Approved Drugs That Induce Heart Regeneration in Mammals

被引：0

作者：

Nguyen, Ngoc U. ^{[1
]}

Ahmed, Mahmoud S. ^{[1
]}

Nakada, Yuji ^{[2
]}

Hsu, Ching-Cheng ^{[1
]}

Farag, Ayman ^{[1
]}

Wang, Ping ^{[1
]}

Menendez-Montes, Ivan ^{[1
]}

Thet, Suwannee ^{[1
]}

Lam, Nicholas T. ^{[1
]}

Tomchick, Diana R. ^{[1
]}

Walcott, Gregory ^{[2
]}

Grishin, Nick V. ^{[1
]}

Zhang, Jianyi J. ^{[2
]}

Sadek, Hesham A. ^{[1
]}

机构：

[1] UT SouthWestern Med Ctr, Dallas, TX USA

[2] Univ Alabama Birmingham, Birmingham, AL USA

来源：

CIRCULATION RESEARCH | 2022年 / 131卷 / 12期

关键词：

Cardiac regeneration; Drug administration;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

19740

引用

页码：E171 / E171

页数：1

共 50 条

[1] Identification of FDA-approved drugs that induce heart regeneration in mammals
Ahmed, Mahmoud Salama
Nguyen, Ngoc Uyen Nhi
Nakada, Yuji
Hsu, Ching-Cheng
Farag, Ayman
Lam, Nicholas T.
Wang, Ping
Thet, Suwannee
Menendez-Montes, Ivan
Elhelaly, Waleed M.
Lou, Xi
Secco, Ilaria
Tomczyk, Mateusz
Zentilin, Lorena
Pei, Jimin
Cui, Miao
Dos Santos, Matthieu
Liu, Xiaoye
Liu, Yan
Zaha, David
Walcott, Gregory
Tomchick, Diana R.
Xing, Chao
Zhang, Cheng Cheng
Grishin, Nick V.
Giacca, Mauro
Zhang, Jianyi
Sadek, Hesham A.
NATURE CARDIOVASCULAR RESEARCH, 2024, 3 (3): : 372 - 388
[2] Identification of FDA-approved drugs that induce heart regeneration in mammals
Mahmoud Salama Ahmed
Ngoc Uyen Nhi Nguyen
Yuji Nakada
Ching-Cheng Hsu
Ayman Farag
Nicholas T. Lam
Ping Wang
Suwannee Thet
Ivan Menendez-Montes
Waleed M. Elhelaly
Xi Lou
Ilaria Secco
Mateusz Tomczyk
Lorena Zentilin
Jimin Pei
Miao Cui
Matthieu Dos Santos
Xiaoye Liu
Yan Liu
David Zaha
Gregory Walcott
Diana R. Tomchick
Chao Xing
Cheng Cheng Zhang
Nick V. Grishin
Mauro Giacca
Jianyi Zhang
Hesham A. Sadek
Nature Cardiovascular Research, 2024, 3 : 372 - 388
[3] Identification of FDA-approved drugs targeting the Farnesoid X Receptor
van de Wiel, Sandra M. W.
Bijsmans, Ingrid T. G. W.
van Mil, Saskia W. C.
van de Graaf, Stan F. J.
SCIENTIFIC REPORTS, 2019, 9 (1)
[4] Identification of FDA-approved drugs targeting the Farnesoid X Receptor
Sandra M. W. van de Wiel
Ingrid T. G. W. Bijsmans
Saskia W. C. van Mil
Stan F. J. van de Graaf
Scientific Reports, 9
[5] Safety of FDA-Approved drugs - Reply
Friedman, MA
Woodcock, J
Lumpkin, MM
Shuren, JE
Hass, AE
Thompson, LJ
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (24): : 2297 - 2298
[6] NONAPPROVED USES OF FDA-APPROVED DRUGS
ANDERSON, BJ
JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1970, 211 (10): : 1705 - &
[7] An analysis of FDA-approved drugs for oncology
Kinch, Michael S.
DRUG DISCOVERY TODAY, 2014, 19 (12) : 1831 - 1835
[8] Identification of FDA-approved Drugs that Computationally Bind to MDM2
Warner, Wayne A.
Sanchez, Ricardo
Dawoodian, Alex
Li, Esther
Momand, Jamil
CHEMICAL BIOLOGY & DRUG DESIGN, 2012, 80 (04) : 631 - 637
[9] Identification of FDA-approved drugs that computationally bind to MDM2.
Warner, W. A.
Sanchez, R.
Dawoodian, A.
Esther, L.
Momand, J.
MOLECULAR BIOLOGY OF THE CELL, 2011, 22
[10] Identification of FDA-approved drugs that target hepatitis B virus transcription
van de Klundert, M. A. A.
Zaaijer, H. L.
Kootstra, N. A.
JOURNAL OF VIRAL HEPATITIS, 2016, 23 (03) : 191 - 201

← 1 2 3 4 5 →